Your shopping cart is currently empty

Ochratoxin α (Ochratoxin alpha) is a degradation product of Ochratoxin A, used for studying Ochratoxin A degradation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $311 | 5 days | 5 days | |
| 5 mg | $426 | 7-10 days | 7-10 days |
| Description | Ochratoxin α (Ochratoxin alpha) is a degradation product of Ochratoxin A, used for studying Ochratoxin A degradation. |
| In vitro | The ROS level of Ochratoxin α (200-400 nM, 48 h) LX-2 cells was significantly increased, and the cell viability was decreased. [1] Ochratoxin α (2.0 μg/ml) significantly induced NLRP3 inflammasome activation and Caspase-1-dependent pyrodeath. The expression of proinflammatory cytokines (IL-6, TNF-α) and pyrogenic genes (GSDMD, IL-1β, IL-18) was increased and the secretion of MDCK cells was increased. [2] |
| In vivo | Ochratoxin α (200 and 1000 μg/kg orally) induced liver fibrosis in mice. [1] Mice with Ochratoxin α(1.0 and 2.0 mg/kg, intrabitoneal injection, once every two days for 14 days) showed renal histological injury and abnormal expression of renal fibrosis molecules (α-SMA, vimentin, TGF-β). Nod-like receptor protein 3 (NLRP3) inflammasome is activated and induces pyrodeath. [2] |
| Synonyms | Ochratoxin alpha |
| Molecular Weight | 256.64 |
| Formula | C11H9ClO5 |
| Cas No. | 19165-63-0 |
| Smiles | ClC1=C2C(=C(O)C(C(O)=O)=C1)C(=O)O[C@H](C)C2 |
| Storage | store at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120 mg/mL (467.58 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (19.48 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.